Kôji Nanba

1.3k total citations
27 papers, 995 citations indexed

About

Kôji Nanba is a scholar working on Pathology and Forensic Medicine, Immunology and Genetics. According to data from OpenAlex, Kôji Nanba has authored 27 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 11 papers in Immunology and 10 papers in Genetics. Recurrent topics in Kôji Nanba's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Viral-associated cancers and disorders (7 papers). Kôji Nanba is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Viral-associated cancers and disorders (7 papers). Kôji Nanba collaborates with scholars based in Japan, United States and Australia. Kôji Nanba's co-authors include Costan W. Berard, Raul C. Braylan, Elaine S. Jaffe, Risa B. Mann, Haruki Wakasa, Michael M. Frank, Marshall E. Kadin, John L. Ziegler, Masahiro Kikuchi and Taizan Suchi and has published in prestigious journals such as New England Journal of Medicine, Cancer and Human Pathology.

In The Last Decade

Kôji Nanba

24 papers receiving 862 citations

Peers

Kôji Nanba
M. Kadin United States
RA Warnke United States
K Minato United States
Yoshizo Kimura Japan
E Matutes United Kingdom
Kenkichi Kita Japan
Ahmed Sawas United States
A.C. Feller Germany
Junichi Kiyasu Japan
S. Poppema Netherlands
M. Kadin United States
Kôji Nanba
Citations per year, relative to Kôji Nanba Kôji Nanba (= 1×) peers M. Kadin

Countries citing papers authored by Kôji Nanba

Since Specialization
Citations

This map shows the geographic impact of Kôji Nanba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kôji Nanba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kôji Nanba more than expected).

Fields of papers citing papers by Kôji Nanba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kôji Nanba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kôji Nanba. The network helps show where Kôji Nanba may publish in the future.

Co-authorship network of co-authors of Kôji Nanba

This figure shows the co-authorship network connecting the top 25 collaborators of Kôji Nanba. A scholar is included among the top collaborators of Kôji Nanba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kôji Nanba. Kôji Nanba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Machii, Takashi, Takaaki Chou, Yokiko Ohe, et al.. (2005). Phase II Clinical Study of Cladribine in the Treatment of Hairy Cell Leukemia. International Journal of Hematology. 82(3). 230–235. 10 indexed citations
2.
Takimoto, Y, et al.. (1996). Anaplastic Large-Cell Lymphoma (KM Lymphoma) with Expression of IL-5 mRIMA and Eosinophilic Invasion. Acta Haematologica. 96(4). 245–248. 10 indexed citations
3.
Takimoto, Y, et al.. (1994). Hodgkin’s Disease Associated with Chronic Myeloid Leukemia. Acta Haematologica. 92(2). 97–100. 1 indexed citations
4.
Takimoto, Y, Hideo Tanaka, Osamu Tanabe, et al.. (1994). A patient with anaplastic large cell lymphoma (Ki-1 lymphoma) showing clonal integration of HTLV-1 proviral DNA.. PubMed. 8(3). 507–9. 13 indexed citations
5.
6.
Yoshizawa, Kaname, K Kiyosawa, Shuhei Yamada, et al.. (1993). Establishment of Epstein-Barr virus-associated lymphoma cell line SUBL with t(2;3)(p11;q27) from a liver transplant patient. Cancer Genetics and Cytogenetics. 71(2). 155–163. 7 indexed citations
7.
Mishima, Hiromu K., et al.. (1991). Primary orbital malignant lymphoma: a clinicopathology study of 17 cases. Graefe s Archive for Clinical and Experimental Ophthalmology. 229(3). 206–209. 5 indexed citations
8.
Imamura, Nobutaka, et al.. (1991). Survival of T- and B-Phenotype Diffuse Aggressive Non-Hodgkin's Lymphomas. Leukemia & lymphoma. 3(5-6). 401–408.
9.
Shibata, Darryl, et al.. (1991). Detection of Human T-Cell Leukemia Virus Type I Proviral Sequences from Fixed Tissues of Seropositive Patients. American Journal of Clinical Pathology. 95(4). 536–539. 9 indexed citations
10.
Ishikawa, Takenori, et al.. (1990). The Identification of a Rabbit-Transmitted Cervical Toxoplasmosis Mimicking Malignant Lymphoma. American Journal of Clinical Pathology. 94(1). 107–110. 8 indexed citations
11.
12.
Kadin, Marshall E., Costan W. Berard, Kôji Nanba, & Haruki Wakasa. (1983). Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States—Japan seminar, September 6 and 7, 1982, in Seattle, Washington. Human Pathology. 14(9). 745–772. 113 indexed citations
13.
Shimoyama, M, et al.. (1982). Binding experiments of muscarinic acetylcholine and dopamine receptors in human brains with emphasis on a case of striatonigral degeneration.. The Japanese Journal of Pharmacology. 32(6). 1157–1166. 4 indexed citations
14.
Suchi, Taizan, Kazuo Tajima, Kôji Nanba, et al.. (1979). SOME PROBLEMS ON THE HISTOPATHOLOGICAL DIAGNOSIS OF NON‐HODGKIN'S MALIGNANT LYMPHOMA— A Proposal of a New Type—. Acta Pathologica Japonica. 29(5). 755–776. 160 indexed citations
15.
Nariuchi, Hideo, et al.. (1978). Antibody Forming Cell Precursors Among Glass-Adhehent Peritoneal Exucate Cells. Immunological Communications. 7(4). 441–459. 5 indexed citations
16.
Braylan, Raul C., Elaine S. Jaffe, Timothy J. Triche, et al.. (1978). Structural and functional properties of the „hairy” cells of leukemic reticuloendotheliosis. Cancer. 41(1). 210–227. 78 indexed citations
17.
Nanba, Kôji, et al.. (1977). Hairy cell leukemia:Enzyme histochemical characterization, with special reference to splenic stromal changes. Cancer. 39(6). 2323–2336. 51 indexed citations
18.
Nanba, Kôji, et al.. (1977). Alkaline Phosphatase-positive Malignant Lymphoma: A Subtype of B-cell Lymphomas. American Journal of Clinical Pathology. 68(5). 535–542. 106 indexed citations
19.
Nanba, Kôji, et al.. (1977). Splenic Pseudosinuses and Hepatic Angiomatous Lesions: Distinctive Features of Hairy Cell Leukemia. American Journal of Clinical Pathology. 67(5). 415–426. 77 indexed citations
20.
Mann, Risa B., Elaine S. Jaffe, Raul C. Braylan, et al.. (1976). Non-Endemic Burkitt's Lymphoma. New England Journal of Medicine. 295(13). 685–691. 174 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Kadin Breakdown of academic impact, for papers by RA Warnke Breakdown of academic impact, for papers by K Minato Breakdown of academic impact, for papers by Yoshizo Kimura Breakdown of academic impact, for papers by E Matutes Breakdown of academic impact, for papers by Kenkichi Kita Breakdown of academic impact, for papers by Ahmed Sawas Breakdown of academic impact, for papers by A.C. Feller Breakdown of academic impact, for papers by Junichi Kiyasu Breakdown of academic impact, for papers by S. Poppema
Rankless by CCL
2026